Randomized clinical trial to evaluate the efficacy of two techniques against chronic hip pain: cooled radiofrequency over sensitive nerves of the hip, compared to intraarticular injection of steroids and local anestethic under fluoroscopic guidance on the hip. - Randomized trial: radiofrequency versus intraarticular local anesthestic and steroids.

JORGE ORDUÑA VALLS0 sites20 target enrollmentApril 9, 2018

Overview

No summary available.

Registry

who.int

Start Date

April 9, 2018

End Date

TBD

Last Updated

7 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Sponsor

JORGE ORDUÑA VALLS

•1\- Patient over 18 years old.
•2\- Chronic hip pain (more than 3 months) that has not responded to conservative treatment, pharmacological therapy, physiotherapy or TENS).
•3\- Mechanical pain in the affected limb with a VAS of at least 50 mm during ambulation.
•4\- Patients for whom it is possible to carry out all the scheduled visits of the study, with the capacity to attend within the established deadlines for the control visits.
•5\- Greater than 50% improvement in the VAS scale after the two anesthetic blocks performed with local anesthetics of different duration (levobupivacaine 0\.25% and mepivacaine 2%)
•6\- Moderate to severe osteoarthrosis determined with degrees Kellgren\-Lawrence II, III, IV.
•7\- Stable doses of analgesics at least 30 days before starting the study.
•8\- Patients who have performed the Oxford Hip Score and WOMAC test 3 months or less before the study.
•9\- Absence of allergy or adverse events known to any of the medications administered: local anesthetics of amide group and iodinated contrasts.
•10\-Negative pregnancy test (women of childbearing age) and commitment to guarantee contraception during the study

•1\- Signs of alarm or infection in the joint affects.
•2\- Signs of active infection, immunosuppression or active HIV.
•3\- Severe psychiatric illnesses.
•4\-Patient carrier of hip prosthesis.
•5\- Pain added to an unexplained weight loss of more than 5% 90 days or less before the start of the study.
•6\- Pain of root origin established in the affected limb, or neurodegenerative diseases of the peripheral nervous system.
•7\- Patients with basic tumor pathology or who have had cancer in the five years prior to inclusion.
•8\- Alterations of the coagulation or taking of anticoagulants / antiaggregants (except aspirin 150 or 300 mg / day) at the beginning of the study, which can not be suspended for basic pathology during a prudent interval for the realization of the technique.
•9\- Patient who has participated in a clinical study for the previous 30 days in which interventions are performed that may affect the results of the study.
•10\- Patient with a diagnosis of disorder due to substance abuse or alcoholism.